{
    "nctId": "NCT00293384",
    "briefTitle": "Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant",
    "officialTitle": "Pilot Study Evaluating Aprepitant (MK-869) for Prevention of Nausea & Vomiting Secondary to High Dose Cyclophosphamide Administered to Patients Underging Undergoing Peripheral Hematopoietic Progenitor Cell Mobilization Prior to Autologous Transplantation",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Nausea and Vomiting, Neuroblastoma, Ovarian Cancer, Testicular Germ Cell Tumor",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "Proportion of Participants With Controlled Acute Vomiting",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Undergoing autologous peripheral blood stem cell transplantation and stem cell mobilization using cyclophosphamide\n* Candidate (per institutional requirements) for autologous peripheral blood stem cell transplantation\n\n  * No psychiatric illness or multi-system organ failure\n* No nausea at baseline\n\nPATIENT CHARACTERISTICS:\n\n* SWOG performance status 0-2\n* Fewer than 5 alcoholic drinks per day within the past year\n* No current illness requiring chronic systemic steroids or requirement for chronic use of anti-emetics\n* No gastrointestinal obstruction or active peptic ulcer disease\n* AST and ALT \u2264 3 times upper limit of normal (ULN)\n* Bilirubin \u2264 3 times ULN\n* Alkaline phosphatase \u2264 3 times ULN\n* Creatinine \u2264 2 mg/dL\n* No known hypersensitivity to any component of the study regimen\n* Not pregnant or nursing\n* Negative pregnancy test\n* Fertile patients must use effective barrier contraception\n* No unrelenting hiccups\n\nPRIOR CONCURRENT THERAPY:\n\n* No chronic therapeutic warfarin \\> 1 mg dose per day\n* No other concurrent investigational agents\n* No concurrent oral contraceptives (except for stopping menses), tolbutamide, phenytoin, midazolam, ketoconazole, rifampin, paroxetine hydrochloride, or diltiazem hydrochloride\n* No concurrent illegal drugs",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}